Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03509766 · ClinicalTrials.gov registry record · NA
Randomized Evaluation of Ten Allergy Skin Prick Test Devices
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03509766: Completed NA study, sponsored by Johns Hopkins University.
NCT03509766 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03509766, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The goal of this study is to compare ten current and readily available FDA approved allergy skin prick devices to determine the most sensitive and specific product and methods used for the diagnosis of allergic disease. The primary outcome will be to determine the analytical sensitivity and specificity of all ten skin prick devices by measuring wheal and flare response to histamine and control diluent in 1mm increments. Secondary outcomes include comparison of skin prick technique, optimum histamine concentration, patient comfort, reproducibility, and the comparability of high-resolution digital images.
Interventions
- DEVICE Histamine skin testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03509766
The ClinicalTrials.gov registry entry for NCT03509766 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Histamine skin testing is the first listed.
NCT03509766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03509766 about?
NCT03509766 is a clinical study titled "Randomized Evaluation of Ten Allergy Skin Prick Test Devices". The goal of this study is to compare ten current and readily available FDA approved allergy skin prick devices to determine the most sensitive and specific product and methods used for the diagnosis of allergic disease. The primary outcome will be to determine the analytical sensitivity and specific...
What is the current status of trial NCT03509766?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2014-01. Estimated completion is 2015-09.
What interventions are being tested in trial NCT03509766?
The interventions under investigation include: Histamine skin testing (DEVICE).
Who is sponsoring clinical trial NCT03509766?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.